28 . 02 .2024
Press release
Galderma to showcase latest updates from its broad, innovative and leading dermatology portfolio at the 2024 American Academy of Dermatology annual meeting
14 . 02 .2024
Press release
Galderma announces regulatory filing acceptance for nemolizumab in prurigo nodularis and atopic dermatitis in the U.S. and EU
08 . 02 .2024
Press release
Galderma takes the ‘Face of Cetaphil®’ to the runway at New York City fashion week
07 . 02 .2024
Press release
Galderma launches ‘NEXT’, a ground-breaking trend report that unveils the future of aesthetics
02 . 02 .2024
Press release
Galderma celebrates 25 years of excellence in biostimulation with Sculptra® at the 2024 IMCAS
25 . 01 .2024
Press release
IMCAS 2024: Galderma to present latest updates from its unparalleled aesthetics portfolio reinforcing its leadership position